当前位置: 首页 > 期刊 > 《中外医疗》 > 201322
编号:13720513
18F—FDG SPECT/CT检查在原发癌灶定位诊断中的意义(2)
http://www.100md.com 2013年8月5日 《中外医疗》 201322
     18F-FDG SPECT/CT检查假阴性多为高分化、低代谢肿瘤,也见于高血糖患者等情况。所以SPECT/CT检查阴性,应结合临床资料和其他影像表现进行鉴别诊断。

    [参考文献]

    [1] Han A,Xue J,Zheng J,et al.Clinical Value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary[J].Cancer Epidemiol,2012,36(5):470-475.

    [2] Yamashita H,Suzuki A,Takahashi Y,et al.Intravascular large B-cell lymphoma with diffuse FDG uptake in the lung by 18FDG-PET/CT without chest CT findings[J].Ann Nucl Med,2012,2(6):515-521.

    [3] Zohar Keidar,Nissim Haim,Luda Guralnik,et al.PET/CT using 18F-FDG in Suspected Lung Cancer Recurrence:Diagnostic Value and Impact on Patient Management[J].J Nunl Med,2004,45(10):1640-1646.

    [4] Jeon SY,Ahn SH,Kim CH. Esophageal and laryngeal cancer incidentally found on 18F-fluorodeoxyglucose positron emission tomography/computed tomography during the staging workup for lung cancer[J].Clin Lung Cancer,2008(9):230-231.

    [5] Greco FA,Erland JB,Pafalovkos D,et al. Carcinoma of unknown primary site:long-term follow-up after taxine-base chemotherapy[J].Proc Am Soc Oncol,2000(19):579.

    (收稿日期:2013-06-05), 百拇医药(贾晓娟等)
上一页1 2